Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes

Table 5 Scales, risk factors and efficiencies, overall and by gender and age group. Each component’s share of total capability efficiency

	All		Male		Female			18–35 years		36–50 years		51–62 years		63–80 years
	Mean	SD	Mean	SD	Mean	SD		Mean	SD	Mean	SD	Mean	SD	Mean	SD
Scales
GenW	61	23	64	23	58	23	*	61	24	58	24	60	23	64	22
MoE	66	22	70	21	62	23	*	61	23	64	22	66	22	71	22	§
FreW	56	21	60	20	52	21	*	52	23	56	21	57	21	60	20	§
ManD	65	19	66	19	63	19		64	21	62	19	64	17	69	16	§
DiEx	57	23	58	24	56	23		56	26	53	23	57	22	63	21	§
NLD	77	22	78	22	76	21		77	22	78	21	77	22	76	22
NLBS	71	27	74	25	68	28	*	70	28	71	27	71	26	70	25
SuDC	81	19	82	18	79	20	*	80	19	78	20	80	19	84	17	§
AcDC	70	20	71	19	68	21		67	21	68	20	69	20	74	19	§
CoDC	80	23	78	24	82	22	*	80	23	79	23	78	24	80	24
MDMT	78	20	77	21	78	20		75	21	75	20	79	20	83	18	§
Risk factors
HbA1c	60.9	11.9	60.3	11.5	61.5	12.2		59.6	13.4	61.4	11.6	61.7	11.8	60.8	10.5
SBP	127.4	14.3	129.1	13.8	125.7	14.6	*	119.1	11.2	124.8	12.6	130.3	13.2	134.7	14.8	§
LDL	2.44	0.76	2.44	0.75	2.44	0.78		2.53	0.74	2.54	0.80	2.44	0.75	2.28	0.73	§
Efficiency
Intermediate	0.68	0.17	0.69	0.18	0.67	0.17		0.68	0.19	0.65	0.17	0.67	0.17	0.72	0.15	§
Capability	0.92	0.06	0.92	0.06	0.91	0.06		0.93	0.06	0.91	0.06	0.91	0.06	0.92	0.05	§
GenW share (%)	10.7	10.7	11.8	12.2	9.6	8.9		10.3	9.9	10.5	11.6	11.0	11.8	10.8	9.6
MoE share (%)	15.9	23.2	19.1	25.1	12.7	20.6	*	11.6	19.7	15.2	22.5	17.2	24.5	19.3	24.9	§
HbA1c’ share (%)	26.9	22.5	26.2	22.6	27.6	22.5		27.9	22.5	26.4	20.9	27.4	23.7	25.9	23.0
SBP’ share (%)	20.7	18.4	17.9	17.4	23.5	19.0	*	29.5	18.6	24.3	18.1	17.0	17.0	1.28	15.4	§
LDL’ share (%)	25.8	22.4	25.0	22.4	26.6	22.3		20.7	20.3	23.7	20.6	27.4	22.8	31.1	24.0	§
n	1456		723		733			351		366		348		391

* = differences between genders (p < 0.001) Kruskal-Wallis. § = difference between age groups (p < 0.001). SD Standard deviation

ISSN: 2191-1991